Omicron News and Research

RSS

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Announcing a new article publication for Zoonoses journal. Shanghai and Hong Kong, China, experienced an outbreak of COVID-19 in early 2022.

15 Feb 2024

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants.

13 Feb 2024

COVID-19's lasting impact on smell and brain health unveiled

Study reviews the impact of COVID-19 on olfactory dysfunction and its link to neurocognitive disorders, highlighting MRI findings and potential treatments for smell loss.

12 Feb 2024

Long COVID in children: A closer look reveals lasting impacts

A comprehensive review in Pediatrics highlights the significant impact of post-acute sequelae of SARS-CoV-2 (PASC) in children, revealing a wide range of long-term symptoms and the need for further research on its prevalence, risk factors, and mechanisms.

11 Feb 2024

Understanding the virological properties of SARS-CoV-2 variant JN.1

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat.

9 Feb 2024

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

9 Feb 2024

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Early estimates show the 2023-24 updated monovalent XBB.1.5 COVID-19 vaccine offers significant protection against symptomatic infection, with effectiveness varying by age and time since vaccination.

4 Feb 2024

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

First boosters, second boosters, monovalent, bivalent. Just like the SARS-CoV-2 virus strain, the vaccines to combat the virus are always changing—and perhaps confusing.

2 Feb 2024

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Researchers found that neonates born to mothers with SARS-CoV-2 infection face an increased risk of respiratory distress, potentially due to an inflammatory response triggered by prenatal exposure.

29 Jan 2024

Study offers insights into who's at risk for long COVID among immunocompromised patients

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

26 Jan 2024

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

How type 2 diabetes and genetic susceptibility to the disease impacted the severity of and mortality risk associated with coronavirus disease 2019.

26 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Omicron News and Research

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Study reveals high prevalence of persistent COVID-19 infections in general population

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

COVID-19's lasting impact on smell and brain health unveiled

Long COVID in children: A closer look reveals lasting impacts

Understanding the virological properties of SARS-CoV-2 variant JN.1

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Study offers insights into who's at risk for long COVID among immunocompromised patients

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

Study shows Omicron variants evade immune system like predecessors, suggesting key evolutionary trait in SARS-CoV-2

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News